---------------------------
OMB APPROVAL
UNITED STATES OMB Number: 3235-0145
SECURITIES AND EXCHANGE COMMISSION Expires: February 28, 2009
Washington, D.C. 20549 Estimated average burden
hours per
response............14.5
---------------------------
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No._________)*
China Agro Sciences Corp.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
16937D 10 5
--------------------------------------------------------------------------------
(CUSIP Number)
Craig V. Butler, Esq. The Lebrecht Group, APLC
9900 Research Drive
Irvine, CA 92618
(949) 635-1240
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
May 1, 2006
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. |_|
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Persons who respond to the collection of information contained in this
form are not required to respond unless the form displays a currently
valid OMB control number.
CUSIP No. 16937D 10 5
--------------------------------------------------------------------------------
1. Names of reporting persons I.R.S. Identification Nos. of above persons
(entities only)
Zhengquan Wang
--------------------------------------------------------------------------------
2. Check the appropriate box if a member of a group (See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC use only
--------------------------------------------------------------------------------
4. Source of funds (See Instructions): OO
--------------------------------------------------------------------------------
5. Check if disclosure of legal proceedings is required pursuant to items
2(d) or 2(e):
--------------------------------------------------------------------------------
6. Citizenship or place of organization: Peoples Republic of China
--------------------------------------------------------------------------------
Number of 7. Sole Voting Power 16,000,000
Shares Bene- --------------------------------------------------------------
ficially 8. Shared Voting Power 0
Owned --------------------------------------------------------------
by Each 9. Sole Dispositive Power 16,000,000
Reporting --------------------------------------------------------------
Person With 10. Shared Dispositive Power 0
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person: 16,000,000
--------------------------------------------------------------------------------
12. Check if the Aggregate amount in Row (11) Excludes Certain Shares (See
Instructions)
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11): 80%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions): IN
--------------------------------------------------------------------------------
ITEM 1. SECURITY AND ISSUER
Common Stock
China Agra Sciences Corp., 100 Wall Street, 15th Floor, New York, NY 10005
ITEM 2. IDENTITY AND BACKGROUND
(a) Name: This statement is filed on behalf of Zhengquan Wang, an
individual ("Mr. Wang" or "Reporting Person").
(b) Residence or Business Address: The address of the Reporting Person
is; 100 Wall Street, 15th Floor New York, NY 10005
(c) Principal Occupation or Employment: President, China Agro Sciences
Corp. 100 Wall Street, 15th Floor New York, NY 10005
(d) During the last five years, the Reporting Person has not been
convicted in a criminal proceeding.
(e) During the last five years, the Reporting Person has not been a
party to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding been
subject to a judgment, decree or final order enjoining future
violations or prohibiting or mandating activities subject to,
federal or state securities law or finding any violation with
respect to such law.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The 16,000,000 shares were received in exchange for 16,000,000 shares of
DaLian Holding Corp. (formerly known as China Agro Sciences Corp.) ("DaLian") in
connection with merger of DaLian and a subsidiary of the Issuer (the "Merger").
ITEM 4. PURPOSE OF TRANSACTION
These shares were acquired in a transaction whereby a subsidiary of the
Issuer merged with an entity controlled by Reporting Person. As a result of the
merger transaction the Reporting Person acquired 80% of the Issuer's outstanding
common stock. This transaction also resulted in change of the Issuer's executive
officers, Board of Directors, and a change in the Issuer's business focus from a
Business Development Company to a development stage company investing in the
herbicide and pesticide industry in the People's Republic of China.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) The Reporting Person now owns 16,000,000 shares of common stock of
China Agro Sciences Corp., which equates to 80% of China Agro's
outstanding common stock.
(b) As to the 16,000,000 shares, Mr. Wang owns the following rights:
Sole Voting Power: 16,00,000
Shared Voting Power: 0
Sole Dispositive Power: 16,000,000
Shared Dispositive Power: 0
(c) None.
(d) None.
(e) Not Applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
None.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
3.1 (1) Articles of Amendment to Articles of Incorporation Changing Name
to China Agro Sciences Corp.
3.2 (1) Articles of Merger Merging DaLian Acquisition Corp. into China
Agro Sciences Corp.
10.1 (1) Agreement and Plan of Merger dated March 15, 2006
10.2 (1) Extension of Closing Date
(1) Incorporated by reference from our Current Report on Form 8-K filed
with the Commission on May 5, 2006.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
May 12, 2006
--------------------------------------------------------------------------------
Date
/s/ Zhengquan Wang
--------------------------------------------------------------------------------
Signature
Zhengquan Wang, President
--------------------------------------------------------------------------------
Name/Title
Attention. Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).